Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Genentech
Company Monitoring Page for Genentech
latest headlines for company on cafepharma
Roche's Vabysmo lands clinical counterpunch in ophthalmology brawl with Eylea
Fierce Pharma
Thu, 10/27/22 - 11:02 am
Tags:
Roche
,
Genentech
,
Vabysmo
,
bispecific antibodies
,
Eylea
Ex-Genentech scientist sentenced to six months in prison for stealing trade secrets
Endpoints
Tue, 10/25/22 - 10:50 am
Tags:
Genentech
,
trade secrets
ArsenalBio lands $70M cash deal with cancer giant Genentech to develop cell therapy
Endpoints
Tue, 09/27/22 - 10:30 am
Tags:
ArsenalBio
,
Genentech
New Genentech Bay Area lab to speed up biologic drug manufacturing with less energy cost
ABC7 News
Wed, 08/31/22 - 10:21 am
Tags:
Genentech
,
drug manufacturing
,
Bay Area
,
California
,
San Francisco
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
Fierce Biotech
Thu, 08/18/22 - 12:36 pm
Tags:
Roche
,
Genentech
,
China
,
Jemincare
,
biobucks
,
prostate cancer
FDA approves Genentech’s sNDA for influenza therapy in children
Pharmaceutical Business Review
Fri, 08/12/22 - 10:19 am
Tags:
Genentech
,
Xofluza
,
FDA
,
pediatric
,
Flu
Roche, Genentech sign license deal with Kiniksa for vixarelimab
Pharmaceutical Business Review
Thu, 08/4/22 - 10:54 am
Tags:
Kiniksa Pharmaceuticals
,
Roche
,
Genentech
,
vixarelimab
,
monoclonal antibodies
Little biotech developing Genentech castoff drug hits hurdle in glioblastoma platform trial
Endpoints
Tue, 08/2/22 - 10:35 am
Tags:
Kazia Therapeutics
,
paxalisib
,
Genentech
,
glioblastoma
Genentech rides up to 2nd target in Bicycle immuno-oncology collab
Fierce Biotech
Tue, 07/12/22 - 10:52 am
Tags:
Genentech
,
Bicycle Therapeutics
,
Roche
,
immuno-oncology
Fierce NextGen: Despite another key trial failure, Alzheimer's therapy developers find reason for optimism
Fierce Biotech
Wed, 06/29/22 - 10:59 am
Tags:
Alzheimer's disease
,
clinical trials
,
crenezumab
,
Roche
,
Genentech
Wipeout: Roche's anti-amyloid attack on presymptomatic Alzheimer's ends in failure
Fierce Biotech
Thu, 06/16/22 - 10:40 am
Tags:
Roche
,
Genentech
,
Alzheimer's disease
,
crenezumab
New Three-Year Data for Genentech’s Evrysdi (risdiplam) Show Long-Term Improvements in Survival and Motor Milestones in Babies With Type 1 Spinal Muscular Atrophy (SMA)
BioSpace
Fri, 04/29/22 - 10:30 am
Tags:
Genentech
,
Evrysdi
,
risdiplam
,
SMA
,
spinal muscular atrophy
Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar
BioSpace
Thu, 04/14/22 - 10:57 am
Tags:
Amneal
,
FDA
,
bevacizumab-maly
,
Genentech
,
Roche
,
Avastin
,
biosimilars
20 years in, Genentech persists and perseveres in Alzheimer's with gantenerumab
Fierce Biotech
Wed, 04/6/22 - 07:44 pm
Tags:
Roche
,
Genentech
,
Alzheimer's disease
,
gantenerumab
JHL's Judas Kiss: an Inside Look at JHL Biotech's Theft from Genentech
BioSpace
Fri, 03/18/22 - 10:44 am
Tags:
JHL Biotech
,
Genentech
,
Roche
,
trade secrets
,
Rituxan
Former CEO And COO Of JHL Biotech Sentenced For Conspiring To Steal Trade Secrets And Commit Wire Fraud Exceeding $101 Million
DOJ
Wed, 03/16/22 - 10:12 am
Tags:
trade secrets
,
wire fraud
,
JHL Biotech
,
Genentech
Aiming to drug genetic modifiers, Roche-partnered biotech bags $31M to fuel a drive toward clinic
Endpoints
Thu, 03/10/22 - 10:27 am
Tags:
Scenic Biotech
,
Roche
,
Genentech
,
genetic modifiers
Roche adds to Genentech's ophthalmology program with $670M in biobucks for Lineage Cell Therapeutics' asset
Fierce Biotech
Mon, 12/20/21 - 11:32 pm
Tags:
Roche
,
Genentech
,
Lineage Cell Therapeutics
,
cell therapy
,
dry age-related macular degeneration
ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma
Endpoints
Tue, 12/14/21 - 11:12 am
Tags:
ASH2021
,
Roche
,
antibody-drug conjugate
,
Polivy
,
Genentech
,
blood cancers
Genentech's tocilizumab shortage due to Covid-19 now hits CAR-T recipients, with FDA offering alternatives to help
Endpoints
Mon, 12/13/21 - 11:01 am
Tags:
Genentech
,
tocilizumab
,
COVID-19
,
CAR-T
,
drug shortages
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.